Fosfestrol

Fosfestrol
Clinical data
Trade names Honvan
AHFS/Drugs.com International Drug Names
ATC code L02AA04 (WHO)
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 13425-53-1 N
PubChem (CID) 3032325
ChemSpider 2297327 YesY
UNII A0E0NMA80F YesY
KEGG D00946 YesY
ChEMBL CHEMBL1200598 N
ECHA InfoCard 100.007.573
Chemical and physical data
Formula C18H22O8P2
Molar mass 428.310 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Fosfestrol (INN, BAN, JAN) (brand names Honvan, Difostilben, Fosfostilben, Fostrolin, Stilbol, Stilphostrol, Vagestrol, among others), also known as diethylstilbestrol diphosphate (USAN), abbreviated as DESDP or DESP, is a synthetic, non-steroidal estrogen of the stilbestrol group that is or has been used in the treatment of prostate cancer.[1][2] It is a prodrug of diethylstilbestrol.[3] The drug has been marketed widely throughout the world, including in the United States, Canada, Europe, Hong Kong, and Mexico.[1]

See also

References

  1. 1 2 Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 332–. ISBN 978-3-88763-075-1.
  2. Shanbhag (1 January 2008). Pharmacology: Prep Manual for Undergraduates. Elsevier India. pp. 463–. ISBN 978-81-312-1153-3.
  3. Urotext (1 January 2001). Urotext-Luts: Urology. Urotext. pp. 386–. ISBN 978-1-903737-03-3.



This article is issued from Wikipedia - version of the 10/11/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.